Evidence map›Paper›PMID 35211361›Full record

ArticleIEEE access : practical innovations, open solutions2021

Service Level Agreements for 5G and Beyond: Overview, Challenges and Enablers of 5G-Healthcare Systems.

Haneya Naeem Qureshi, Marvin Manalastas, Syed Muhammad Asad Zaidi, Ali Imran, Mohamad Omar Al Kalaa

Open access · goldAbstract read
In one paragraph

Article in IEEE access : practical innovations, open solutions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
10.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. MDT-based Intelligent Route Selection for 5G-Enabled Connected Ambulances.Healthcom. International Conference on e-Health Networking, Applications and Services · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Haneya Naeem QureshiCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0003-4327-0556
Marvin ManalastasSchool of Electrical and Computer Engineering, The University of Oklahoma-Tulsa, Tulsa, OK 74135, USA.
Syed Muhammad Asad ZaidiSchool of Electrical and Computer Engineering, The University of Oklahoma-Tulsa, Tulsa, OK 74135, USA.ORCID 0000-0001-9879-9655
Ali ImranSchool of Electrical and Computer Engineering, The University of Oklahoma-Tulsa, Tulsa, OK 74135, USA.ORCID 0000-0003-0564-6356
Mohamad Omar Al KalaaCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0001-7435-4870
University of Oklahoma · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

5G and beyond networks will transform the healthcare sector by opening possibilities for novel use cases and applications. Service level agreements (SLAs) can enable 5G-enabled medical device use cases by documenting how a medical device communication requirements are met by the unique characteristics of 5G networks and the roles and responsibilities of the stakeholders involved in offering safe and effective 5G-enabled healthcare to patients. However, there are gaps in this space that should be addressed to facilitate the efficient implementation of 5G technology in healthcare. Current literature is scarce regarding SLAs for 5G and is absent regarding SLAs for 5G-enabled medical devices. This paper aims to bridge these gaps by identifying key challenges, providing insight, and describing open research questions related to SLAs in 5G and specifically 5G-healthcare systems. This is helpful to network service providers, users, and regulatory authorities in developing, managing, monitoring, and evaluating SLAs in 5G-enabled medical systems.

Indexed as

5G5G-enabled medical devicehealthcareService level agreements

Identifiers

PMID35211361
PMCPMC8864549
OpenAlexW3117981770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.